Social Capital Suvretta Holdings Corp. IV (DNAD)
| Market Cap | 256.00M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | n/a |
| Shares Out | 25.60M |
| EPS (ttm) | n/a |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Dividend Yield | n/a |
| Trading Day | n/a |
| Last Price | n/a |
| Previous Close | n/a |
| Change ($) | n/a |
| Change (%) | n/a |
| Day's Open | n/a |
| Day's Range | n/a |
| Day's Volume | n/a |
| 52-Week Range | n/a |
One of the most famous voices in the SPAC industry is launching four new SPACs and also making several changes to his existing lineup of SPACs and former SPACs.
Today's SPAC highlight came post market as Chamath dropped four new SPAC S-1s for $800M total. JWS vote passes, with TSIA and JIH set to vote tomorrow.
Four blank-check companies, backed by venture investor Chamath Palihapitiya, are looking to raise a total of $800 million through initial public offerings with a focus on acquiring biotechnology firms, ...
Social Capital Suvretta Holdings Corp. IV has filed to go public with an IPO on the NASDAQ.
About DNAD
Social Capital Suvretta Holdings Corp. IV is a newly incorporated blank check company, incorporated for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. We intend to focus our search for a target business operating in the biotechnology industry and within the immunology subsector of such industry. The biopharmaceutical industry has fine-tuned its understanding of the immune system over the past several decades, facilitating the devel... [Read more...]
| Industry Blank Checks / SPAC | IPO Date Pending |
| CEO Chamath Palihapitiya | Country United States |
| Stock Exchange NASDAQ | Ticker Symbol DNAD |